Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BPH Global Limited, formerly known as Stemcell United Limited, is an Australian biotechnology company specializing in the development and commercialization of plant-based health and beauty products. The company leverages its proprietary plant stem cell technology to produce high-value ingredients for Traditional Chinese Medicine (TCM), including Dendrobium officinale and Resina Draconis. BPH Global has also diversified its portfolio into the industrial hemp and seaweed sectors, focusing on sustainable plant-based proteins and nutraceuticals like sea grapes (Caulerpa lentillifera). Headquartered in Sydney with operations in Singapore and China, the company targets the wellness, functional food, and cosmetic markets across the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell United.